Welcome to Medications.com

Arpida Reports Progress in Pivotal Phase III Trial With TLT ... - Genetic Engineering News (press release)

The comparator is 8% ciclopirox lacquer (Penlac(R)) applied daily to nails that have not undergone a prior laser pre-treatment. The treatment duration will ...

http://www.genengnews.com/news/bn... | Posted: Tue Jan 22 03:31:20 -0500 2008




Frequently Reported Side Effects of Penlac Nail Lacquer

© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea